A Flicker of Hope in the Shadow of Brain Tumors The promise of a new vaccine against brain tumors has sent shockwaves through medical research circles.
High grade astrocytomas, one of the most aggressive types of tumors, have an almost 100% likelihood of returning after treatment.
Patients often live no more than five years after diagnosis, despite intensive chemotherapy and radiation therapy. A recent study published in Nature offers a glimmer of hope.